PGP and cancer: The upregulation of Pgp driven by HIF1-α has been observed in several cancers, including liver [52], laryngeal, lung [53] and breast [54] cancers, along with malignant pleural mesothelioma [55] and chronic lymphocytic leukemia in B-cells [56].